Trial intelligence / Profile preview

AVE5530 add-on to high-dose statins in severe primary hypercholesterolemia

2008-002849-23Phase 3Completed

Sponsor
Sanofi
Start
Sep 2008
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised, double-blind trial of Canosimibe in hypercholesterolemia (3 arms), sponsored by Sanofi. Started Sep 2008; status: completed.

02

Drugs

Canosimibe
03

Conditions

hypercholesterolemia

Beyond the preview

Go deeper on 2008-002849-23.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2008-002849-23.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call